0
Prescription Medicine
₹20274
₹3041.0Cashback (15%)(Inclusive of all Taxes)
Offers & DiscountsGet Free delivery (₹99) with
Actemra 200mg/10ml Injection 10 ml belongs to the class of 'immunosuppressants', primarily used to treat rheumatoid arthritis, ankylosing spondylitis, and giant cell arteritis (inflammation of the lining of your arteries) in adults. It is also used to treat rheumatoid arthritis in children, such as systemic juvenile idiopathic arthritis (SJIA) and polyarticular juvenile idiopathic arthritis (PJIA). Rheumatoid arthritis is an autoimmune disease in which the body's immune system attacks its own cells and cause joint pain with inflammation. Actemra 200mg/10ml Injection 10 ml is currently being trialled to treat breathing complications in COVID-19 (Corona Virus Disease-19) patients.
Actemra 200mg/10ml Injection 10 ml consists of 'Tocilizumab' that belongs to the class of 'interleukin inhibitors.' It works by blocking the Interleukin-6 (IL-6), a substance released by the body that causes inflammation. Lately, Actemra 200mg/10ml Injection 10 ml is also being used in COVID-19 infection to reduce the severity of inflammation and damage in the lungs. It is thought to decrease the cytokine storm, an excessive immune response that occurs in the lungs of a COVID-19 infected person.
Your doctor will decide the dose and duration based on the medical condition. Common side effects of Actemra 200mg/10ml Injection 10 ml include runny nose, sinus pain, sore throat, increased blood pressure, pain and swelling at the injection site, and headache. These side effects are not familiar to everyone and vary individually. However, if the side effects are persistent, please reach out to your doctor.
Before starting Actemra 200mg/10ml Injection 10 ml, inform your doctor if you have any liver, heart or kidney diseases, stomach and intestinal ulcers, multiple sclerosis (nerve and muscle disease), diabetes, weak immune system (HIV), hepatitis B, cancer, and active infections. Let your doctor know if you are pregnant or breastfeeding before starting Actemra 200mg/10ml Injection 10 ml. Actemra 200mg/10ml Injection 10 ml may cause dizziness, so drive only if you are alert and focused. Actemra 200mg/10ml Injection 10 ml should not be given to children under two years of age as safety has not been established. Avoid consuming alcohol along with Actemra 200mg/10ml Injection 10 ml as it could lead to increased dizziness and risk of liver damage.
Actemra 200mg/10ml Injection 10 ml is used in the treatment of Rheumatoid arthritis, Ankylosing spondylitis, and giant cell arteritis. The detailed uses of Actemra 200mg/10ml Injection 10 ml are as follows:
Actemra 200mg/10ml Injection 10 ml treats pain, redness, and inflammation (swelling) in patients with rheumatoid arthritis, ankylosing spondylitis, and giant cell arteritis. It contains 'Tocilizumab,' an 'interleukin inhibitor.' It works by blocking the Interleukin-6 (IL-6), a substance released by the body that causes inflammation. Lately, Actemra 200mg/10ml Injection 10 ml is also being used in COVID-19 infection to reduce breathing complications, the severity of inflammation, and damage in the lungs. It is used to decrease the cytokine storm, an excessive immune response that occurs in the lungs of a COVID-19 infected person.
Caution
You are recommended to avoid alcohol consumption if you are being treated with Actemra 200mg/10ml Injection 10 ml. Alcohol intake, along with Actemra 200mg/10ml Injection 10 ml, may cause increased dizziness and risk of stomach bleeding/ulcers.
Caution
Actemra 200mg/10ml Injection 10 ml is a pregnancy category C drug and is not recommended during pregnancy since animal studies showed harmful effects on the developing baby. Your doctor will prescribe Actemra 200mg/10ml Injection 10 ml only if the benefit outweighs the risk.
Caution
It is not known if Actemra 200mg/10ml Injection 10 ml passes into the breastmilk when used by breastfeeding mother. Your doctor will prescribe Actemra 200mg/10ml Injection 10 ml only if the benefit outweighs the risk.
Unsafe
Actemra 200mg/10ml Injection 10 ml may make you feel dizzy and sleepy. Do not drive or operate machinery if you experience dizziness or drowsiness.
Caution
Please consult your doctor since Actemra 200mg/10ml Injection 10 ml should be used with caution in patients with liver impairment/liver disease. Dose adjustment may be needed in patients with liver impairment. However, Actemra 200mg/10ml Injection 10 ml is not recommended in patients with active liver diseases.
Caution
Please consult your doctor since Actemra 200mg/10ml Injection 10 ml should be used with caution in patients with kidney impairment/kidney disease. Dose adjustment may be required.
Caution
Actemra 200mg/10ml Injection 10 ml is not recommended in children younger than two years of age.
Caution
Actemra 200mg/10ml Injection 10 ml should be administered with caution in patients with heart problems. Therefore, please talk to your doctor before receiving Actemra 200mg/10ml Injection 10 ml.
Caution
Actemra 200mg/10ml Injection 10 ml should be administered with caution in older adults. Always seek medical advice before receiving it.
Have a query?
Keep Refrigerated. Do not freeze.
Inform your doctor if you have any liver, heart or kidney diseases, stomach and intestinal ulcers (diverticulitis), multiple sclerosis (nerve and muscle disease), low blood cell count, diabetes, weak immune system (HIV), hepatitis B, cancer, and active infections before starting Actemra 200mg/10ml Injection 10 ml. Avoid close contact with people who have infections like chickenpox, measles, tuberculosis, and flu that can be easily spread. Thoroughly wash your hands to prevent the spread of infection. Do not take live vaccines while being treated with Actemra 200mg/10ml Injection 10 ml to prevent any serious consequences. Actemra 200mg/10ml Injection 10 ml may cause dizziness and drowsiness, so drive only if you are alert and focused. Avoid consuming alcohol along with Actemra 200mg/10ml Injection 10 ml as it could lead to increased dizziness and risk of stomach bleeding/ulcers. Actemra 200mg/10ml Injection 10 ml is not recommended in children younger than two years of age as safety and efficacy is not established. Store Actemra 200mg/10ml Injection 10 ml at temperatures of 2°C to 8°C. Do not freeze the vial.
Login/Sign Up
Login/Sign Up
Actemra 200mg/10ml Injection 10 ml contains Tocilizumab, an immunosuppressant. It blocks the action of Interleukin-6 (IL-6), a substance released by the body that causes inflammation. Thus, it helps in decreasing pain and inflammation in various diseases like rheumatoid arthritis, ankylosing spondylitis, and giant cell arteritis.
When a person is infected with the coronavirus, his/her immune system responds in such a way that it sends useful immune chemicals to the affected areas of the lungs to fight the infection. However, in some people, this release of immune chemicals is overactive, resulting in a cytokine storm, an excessive immune response in the lungs. This can further lead to severe breathing complications in an infected person. Actemra 200mg/10ml Injection 10 ml reduces this cytokine storm and further prevents the inflammation and damage in the lungs of a COVID-19 infected person.
Though Tocilizumab in Actemra 200mg/10ml Injection 10 ml is under the clinical trial stage of development by FDA for being used in COVID-19 infection, it is currently used to treat breathing complications for COVID-19 patients. It is known to show improvement in pneumonia during coronavirus infection.
Actemra 200mg/10ml Injection 10 ml is not recommended for every person infected with the coronavirus. Actemra 200mg/10ml Injection 10 ml has potential hazards and is only prescribed by doctors in patients with severe breathing difficulties and who have highly dropping saturation levels (blood oxygen level (SpO2)).
Actemra 200mg/10ml Injection 10 ml is to be carefully administered with caution in patients under doctor's supervision only since it can cause potential side effects like elevated liver enzymes, neutropenia (low levels of neutrophils), and thrombocytopenia (low levels of platelets). It can also cause serious viral infections like hepatitis B, bacterial infections including active tuberculosis, and fungal infections including candidiasis, aspergillosis, and pneumocystis.
Actemra 200mg/10ml Injection 10 ml affects your immune system and makes you more susceptible to infections. Hence, it is not recommended in people with active infections like tuberculosis, hepatitis B, abnormal liver enzymes, and platelet counts less than 50,000. Actemra 200mg/10ml Injection 10 ml can also increase the risk of developing cancers; hence it is essential to mention your doctor if you had a history of any cancer.
Even if there is no improvement after administering Actemra 200mg/10ml Injection 10 ml, your doctor may suggest an alternate course. Please note that Actemra 200mg/10ml Injection 10 ml does not reverse the damage caused due to coronavirus infection, but it will further prevent the inflammation of the lungs. It is also advised to medically examine for other lung and heart related dysfunctions even the patient suffers breathlessness after Actemra 200mg/10ml Injection 10 ml administration.
It is not recommended to get live vaccines like measles, mumps, rubella (MMR), polio, rotavirus, typhoid, yellow fever, varicella (chickenpox), zoster (shingles), and nasal flu (influenza) vaccine while being treated with Actemra 200mg/10ml Injection 10 ml. This could lead to a severe infection. Please consult a doctor before you start Actemra 200mg/10ml Injection 10 ml if you are undergoing any vaccinations.
The common side effects of the Actemra 200mg/10ml Injection 10 ml are headache, runny nose or sneezing, redness, itching, pain, or swelling in the place where injected, constipation, diarrhea, and Increased blood pressure. However, these symptoms vanish as your body adjusts to the medication. If these symptoms become worse, please consult a doctor for relief.
If you have stomach or intestinal ulcers (diverticulitis), inform your doctor before receiving Actemra 200mg/10ml Injection 10 ml. Your doctor will assess your condition and determine whether Actemra 200mg/10ml Injection 10 ml is safe for you, adjusting the dosage if necessary to minimize risks and ensure effective treatment.
Actemra 200mg/10ml Injection 10 ml is a versatile medication that can help manage various conditions. It's used to treat adults with rheumatoid arthritis, ankylosing spondylitis, and giant cell arteritis. Children with systemic juvenile idiopathic arthritis (SJIA) and polyarticular juvenile idiopathic arthritis (PJIA) can also benefit from Actemra 200mg/10ml Injection 10 ml. Additionally, hospitalized adults with COVID-19 may be treated with Actemra 200mg/10ml Injection 10 ml to manage breathing complications and reduce the risk of respiratory failure. However, it's crucial to note that Actemra 200mg/10ml Injection 10 ml should only be used under the guidance and supervision of a qualified healthcare professional, who will determine the appropriate treatment course based on individual patient needs and circumstances.
Actemra 200mg/10ml Injection 10 ml is not recommended for all COVID-19 patients. It is typically reserved for hospitalized patients with severe COVID-19 who are receiving corticosteroids and require supplemental oxygen or mechanical ventilation. This is because the medication can have significant side effects and should be administered under close medical supervision in a monitored clinical setting.
If Actemra 200mg/10ml Injection 10 ml doesn't work after the first dose, your healthcare provider may recommend up to three additional doses, spaced at least 8 hours apart. However, if your symptoms persist or worsen, seek immediate medical attention for further evaluation and alternative treatments. Remember, never take an overdose or stop treatment without consulting your doctor, as this can have serious consequences.
Disclaimer
